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Introduction
Acinetobacter infections have increased and gained atten-
tion because of the organism’s prolonged environmental
survival and propensity to develop antimicrobial drug
resistance [1],[2]. We performed a retrospective, matched
cohort investigation at a tertiary care hospital in a tier II
city hospital of India to examine morbidity and mortality
outcome of patients with multidrug-resistant (MDR) Aci-
netobacter (AB) infection compared with patients with
MDR non-Acinetobacter (non-AB) infections.
Objectives
To study the outcome difference in terms of morbidity
and mortality in critically ill patients with MDR infections.
Methods
Patient records from the last 3 years from 2011 through
2013 were studied (n = 104) to examine outcomes of hos-
pitalized patient in terms of number of organ dysfunctions,
ICU length of stay, hospital length of stay and mortality in
patients infected with MDR AB infection compared with
the patients with MDR non-AB infection.
Results
MDR AB-infected patients (n = 45, 43%) had greater
number oforgan dysfunctions, and higher mean lengths
of hospital stay (8.4 days vs. 6.1 days) and ICU stay (5.3
days vs. 0.8 days) after the index day than MDR non-AB
infection (n = 59, 57%) (Table 1). In-hospital mortality
rates for patients with MDR AB infections (42%) were
higher than for MDR non-AB infection (10%). F critical =
3.934253.
Conclusions
We demonstrated in patients infected with MDR strains
of any organism that patients infected with Acinetobacter
have greater number of organ dysfunction, longer lengths
of stay in both the hospital and the ICU as well as
increased mortality than patients infected with non-
Acinetobacter infection when we controlled for severity
of illness.
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Table 1
Outcome evaluated MDR AB MDR
non-AB
p value f value
Mean length of stay after
index day
8.488889 6.101695 0.029299 4.886684
Mean ICU stay after
index day
5.311111 0.864407 1.73*10-11 57.30083
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